CIK 0001740279
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
IN8BIO, INC.
Sign in to watch- Ticker
- INAB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 825462585
- Phone
- +1 646-600-6438
- Business address
- EMPIRE STATE BUILDING, 350 5TH AVENUE, SUITE 5330, NEW YORK, NY, 10118
- Former names
- Incysus Therapeutics, Inc.
- 8-K Event Executive or director change
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Delisting notice · Director nominations
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Results of operations
- 8-K Event Material agreement · Unregistered share sale · Shareholder rights changed
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- 8-K Event Exit or restructuring costs · Other events
- 8-K Event Other events
- 8-K Event Results of operations
- 8-K Event Shareholder vote results · Other events
- 8-K Event Other events
- 8-K Event Results of operations
- 8-K Event Results of operations
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- 8-K Event Other events
- 8-K Event Executive or director change · Bylaws or fiscal year change
Page 2 of 4 · 77 filings